Colgate-Palmolive Company $CL Stock Holdings Lifted by West Oak Capital LLC

Key Points

• West Oak Capital LLC has increased its holdings in Colgate-Palmolive by 12.5%, now owning 30,889 shares worth approximately $2.8 million.
• Colgate-Palmolive's recent quarterly earnings report showed an EPS of $0.92, exceeding analyst estimates and representing a year-over-year revenue increase of 1.0%.
• The company plans to distribute a quarterly dividend of $0.52 per share on November 14th, with a current dividend yield of 2.6%.

West Oak Capital LLC raised its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 12.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,889 shares of the company's stock after purchasing an additional 3,432 shares during the period. West Oak Capital LLC's holdings in Colgate-Palmolive were worth $2,808,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Westend Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 111.1% during the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company's stock valued at $25,000 after purchasing an additional 140 shares in the last quarter. Cornerstone Planning Group LLC raised its holdings in Colgate-Palmolive by 1,913.3% during the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after buying an additional 287 shares in the last quarter. Saudi Central Bank bought a new position in Colgate-Palmolive during the first quarter valued at about $29,000. Vermillion Wealth Management Inc. bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $31,000. Finally, Ransom Advisory Ltd acquired a new position in shares of Colgate-Palmolive during the 1st quarter valued at about $33,000. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $79.36 on Tuesday. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The company has a market cap of $64.14 billion, a PE ratio of 22.29, a price-to-earnings-growth ratio of 4.22 and a beta of 0.35. The firm has a fifty day moving average price of $84.78 and a two-hundred day moving average price of $89.05. Colgate-Palmolive Company has a fifty-two week low of $79.29 and a fifty-two week high of $104.49.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the prior year, the business earned $0.91 earnings per share. The firm's revenue for the quarter was up 1.0% on a year-over-year basis. Analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend is Friday, October 17th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.43%.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on CL shares. UBS Group reduced their target price on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a report on Thursday, July 17th. Morgan Stanley reduced their price objective on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating for the company in a research note on Monday, August 4th. Citigroup lowered their target price on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research note on Monday, August 4th. JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Finally, Barclays upped their price target on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a report on Tuesday, July 15th. Seven equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of "Moderate Buy" and an average target price of $98.00.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.